ISPOR-Italy Rome Chapter and Cencora PharmaLex, have launched the second edition of the ExploRare. The project was established in 2022 with the aim of critically and proactively reviewing the process leading to the reimbursement of orphan and rare disease drugs, in order to contribute to linear access and a better definition of value.
The upcoming second edition addresses the following topics:
- The horizon scanning development and the analysis of potential critical evaluation issues that emerged in the first edition of ExploRare.
- The pharmaceutical expenditure projection generated by orphan and rare disease drugs in Italy.
STEERING COMMITTEE:
Prof. Pier Luigi Canonico, Adjunct Professor of Pharmacology at Università del Piemonte Orientale, Novara
Prof. Claudio Jommi, Professor of Health Care Management, Department of Pharmaceutical Sciences at Università del Piemonte Orientale, Novara
Dr. Fulvio Luccini, Managing Director Market Access Italy, Cencora Pharmalex
Prof. Andrea Marcellusi, President ISPOR Italy – Rome Chapter
REGISTER HERE VINCENT ONAIR – ExploRare 2.0
EVENT PROGRAM www.explorare-rare.it
The workshop will be held in mixed mode: in presence and at a distance to allow the participation of all in consistency with company policies.
For further information, please contact Cristina.conti@pharmalex.com
